Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1997 May;71(5):4157–4160. doi: 10.1128/jvi.71.5.4157-4160.1997

CD46 short consensus repeats III and IV enhance measles virus binding but impair soluble hemagglutinin binding.

P Devaux 1, C J Buchholz 1, U Schneider 1, C Escoffier 1, R Cattaneo 1, D Gerlier 1
PMCID: PMC191575  PMID: 9094700

Abstract

The binding of a recombinant soluble form of the measles virus (MV) hemagglutinin (sH) to cells expressing hybrid CD46/CD4 proteins was compared to that of purified virus. For binding of both ligands, both CD46 external short consensus repeats I and II (SCR I and II) in the natural order were essential. The addition of SCR III and IV enhanced virus binding but inhibited sH binding. Accordingly, this lowered the ability of sH to compete with MV binding. Antihemagglutinin monoclonal antibodies selectively inhibited the binding of either sH or MV. Thus, sH and MV share a common binding site in SCR I and II but differ in their apparent avidity to CD46 under the influence of SCR III and IV.

Full Text

The Full Text of this article is available as a PDF (120.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong G. D., Paul R. W., Lee P. W. Studies on reovirus receptors of L cells: virus binding characteristics and comparison with reovirus receptors of erythrocytes. Virology. 1984 Oct 15;138(1):37–48. doi: 10.1016/0042-6822(84)90145-4. [DOI] [PubMed] [Google Scholar]
  2. Bibb J. A., Witherell G., Bernhardt G., Wimmer E. Interaction of poliovirus with its cell surface binding site. Virology. 1994 May 15;201(1):107–115. doi: 10.1006/viro.1994.1270. [DOI] [PubMed] [Google Scholar]
  3. Buchholz C. J., Gerlier D., Hu A., Cathomen T., Liszewski M. K., Atkinson J. P., Cattaneo R. Selective expression of a subset of measles virus receptor-competent CD46 isoforms in human brain. Virology. 1996 Mar 1;217(1):349–355. doi: 10.1006/viro.1996.0122. [DOI] [PubMed] [Google Scholar]
  4. Buchholz C. J., Schneider U., Devaux P., Gerlier D., Cattaneo R. Cell entry by measles virus: long hybrid receptors uncouple binding from membrane fusion. J Virol. 1996 Jun;70(6):3716–3723. doi: 10.1128/jvi.70.6.3716-3723.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Carel J. C., Myones B. L., Frazier B., Holers V. M. Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection. J Biol Chem. 1990 Jul 25;265(21):12293–12299. [PubMed] [Google Scholar]
  6. Devaux P., Loveland B., Christiansen D., Milland J., Gerlier D. Interactions between the ectodomains of haemagglutinin and CD46 as a primary step in measles virus entry. J Gen Virol. 1996 Jul;77(Pt 7):1477–1481. doi: 10.1099/0022-1317-77-7-1477. [DOI] [PubMed] [Google Scholar]
  7. Dörig R. E., Marcil A., Chopra A., Richardson C. D. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell. 1993 Oct 22;75(2):295–305. doi: 10.1016/0092-8674(93)80071-l. [DOI] [PubMed] [Google Scholar]
  8. Gerlier D., Trescol-Biémont M. C., Varior-Krishnan G., Naniche D., Fugier-Vivier I., Rabourdin-Combe C. Efficient major histocompatibility complex class II-restricted presentation of measles virus relies on hemagglutinin-mediated targeting to its cellular receptor human CD46 expressed by murine B cells. J Exp Med. 1994 Jan 1;179(1):353–358. doi: 10.1084/jem.179.1.353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gerlier D., Varior-Krishnan G., Devaux P. CD46-mediated measles virus entry: a first key to host-range specificity. Trends Microbiol. 1995 Sep;3(9):338–345. doi: 10.1016/s0966-842x(00)88972-6. [DOI] [PubMed] [Google Scholar]
  10. Giraudon P., Wild T. F. Correlation between epitopes on hemagglutinin of measles virus and biological activities: passive protection by monoclonal antibodies is related to their hemagglutination inhibiting activity. Virology. 1985 Jul 15;144(1):46–58. doi: 10.1016/0042-6822(85)90303-4. [DOI] [PubMed] [Google Scholar]
  11. Iwata K., Seya T., Ueda S., Ariga H., Nagasawa S. Modulation of complement regulatory function and measles virus receptor function by the serine-threonine-rich domains of membrane cofactor protein (CD46). Biochem J. 1994 Nov 15;304(Pt 1):169–175. doi: 10.1042/bj3040169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Iwata K., Seya T., Yanagi Y., Pesando J. M., Johnson P. M., Okabe M., Ueda S., Ariga H., Nagasawa S. Diversity of sites for measles virus binding and for inactivation of complement C3b and C4b on membrane cofactor protein CD46. J Biol Chem. 1995 Jun 23;270(25):15148–15152. doi: 10.1074/jbc.270.25.15148. [DOI] [PubMed] [Google Scholar]
  13. Jin Y. M., Pardoe I. U., Burness A. T., Michalak T. I. Identification and characterization of the cell surface 70-kilodalton sialoglycoprotein(s) as a candidate receptor for encephalomyocarditis virus on human nucleated cells. J Virol. 1994 Nov;68(11):7308–7319. doi: 10.1128/jvi.68.11.7308-7319.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Maisner A., Alvarez J., Liszewski M. K., Atkinson D. J., Atkinson J. P., Herrler G. The N-glycan of the SCR 2 region is essential for membrane cofactor protein (CD46) to function as a measles virus receptor. J Virol. 1996 Aug;70(8):4973–4977. doi: 10.1128/jvi.70.8.4973-4977.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Maisner A., Schneider-Schaulies J., Liszewski M. K., Atkinson J. P., Herrler G. Binding of measles virus to membrane cofactor protein (CD46): importance of disulfide bonds and N-glycans for the receptor function. J Virol. 1994 Oct;68(10):6299–6304. doi: 10.1128/jvi.68.10.6299-6304.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Malvoisin E., Wild F. Characterization of a secreted form of measles virus haemagglutinin expressed from a vaccinia virus recombinant. J Gen Virol. 1994 Dec;75(Pt 12):3603–3609. doi: 10.1099/0022-1317-75-12-3603. [DOI] [PubMed] [Google Scholar]
  17. Malvoisin E., Wild T. F. Measles virus glycoproteins: studies on the structure and interaction of the haemagglutinin and fusion proteins. J Gen Virol. 1993 Nov;74(Pt 11):2365–2372. doi: 10.1099/0022-1317-74-11-2365. [DOI] [PubMed] [Google Scholar]
  18. Manchester M., Valsamakis A., Kaufman R., Liszewski M. K., Alvarez J., Atkinson J. P., Lublin D. M., Oldstone M. B. Measles virus and C3 binding sites are distinct on membrane cofactor protein (CD46). Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):2303–2307. doi: 10.1073/pnas.92.6.2303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Moebius U., Clayton L. K., Abraham S., Harrison S. C., Reinherz E. L. The human immunodeficiency virus gp120 binding site on CD4: delineation by quantitative equilibrium and kinetic binding studies of mutants in conjunction with a high-resolution CD4 atomic structure. J Exp Med. 1992 Aug 1;176(2):507–517. doi: 10.1084/jem.176.2.507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Moore J. P., McKeating J. A., Huang Y. X., Ashkenazi A., Ho D. D. Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates. J Virol. 1992 Jan;66(1):235–243. doi: 10.1128/jvi.66.1.235-243.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Naniche D., Varior-Krishnan G., Cervoni F., Wild T. F., Rossi B., Rabourdin-Combe C., Gerlier D. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol. 1993 Oct;67(10):6025–6032. doi: 10.1128/jvi.67.10.6025-6032.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Russell R., Paterson R. G., Lamb R. A. Studies with cross-linking reagents on the oligomeric form of the paramyxovirus fusion protein. Virology. 1994 Feb 15;199(1):160–168. doi: 10.1006/viro.1994.1108. [DOI] [PubMed] [Google Scholar]
  23. Sakihama T., Smolyar A., Reinherz E. L. Oligomerization of CD4 is required for stable binding to class II major histocompatibility complex proteins but not for interaction with human immunodeficiency virus gp120. Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6444–6448. doi: 10.1073/pnas.92.14.6444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Seya T. Human regulator of complement activation (RCA) gene family proteins and their relationship to microbial infection. Microbiol Immunol. 1995;39(5):295–305. doi: 10.1111/j.1348-0421.1995.tb02205.x. [DOI] [PubMed] [Google Scholar]
  25. Tanner J., Whang Y., Sample J., Sears A., Kieff E. Soluble gp350/220 and deletion mutant glycoproteins block Epstein-Barr virus adsorption to lymphocytes. J Virol. 1988 Dec;62(12):4452–4464. doi: 10.1128/jvi.62.12.4452-4464.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. van Binnendijk R. S., van der Heijden R. W., van Amerongen G., UytdeHaag F. G., Osterhaus A. D. Viral replication and development of specific immunity in macaques after infection with different measles virus strains. J Infect Dis. 1994 Aug;170(2):443–448. doi: 10.1093/infdis/170.2.443. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES